Indicações de rastreamento de câncer de mama, colo do útero e colorretal
Quais as indicações de rastreio de cancer de mama, colo de útero e colorretal
Summary
Below is a concise, evidence‑based overview of screening indications for breast, cervical (cervix), and colorectal cancer in average‑risk, asymptomatic adults, based mainly on USPSTF recommendations. Adapt these to your local (e.g., Brazilian or European) guidelines, which may differ slightly in age cut‑offs and intervals.
1. Breast Cancer Screening (mammography)
Population: Average‑risk women (no known BRCA mutation, no prior breast cancer, no chest radiation at young age, no strong hereditary syndrome).
- Start age:
- USPSTF 2024: begin at 40 years.[1]
- Age 40–74 years:
- Screening mammography every 2 years (biennial).[1]
- ≥75 years:
- Evidence is insufficient for a routine recommendation; decision should be individualized based on life expectancy, comorbidities, and prior screening.[1]
High‑risk women (e.g., BRCA1/2, strong family history, prior chest radiation):
- Typically need earlier and more intensive screening (often annual mammography ± MRI starting before 40); follow high‑risk guidelines, not general‑population USPSTF.
2. Cervical (Cervix) Cancer Screening
Population: Women and people with a cervix, average risk (immunocompetent, no history of high‑grade CIN2+ or cervical cancer).
Ages 21–29 years
Ages 30–65 years
Options (any one of the following):[3][4]
- Cytology (Pap) alone every 3 years, or
- High‑risk HPV (hrHPV) testing alone every 5 years, or
- Co‑testing (Pap + hrHPV) every 5 years.
Younger than 21 years
- Do NOT screen (harms outweigh benefits).[3]
>65 years
- Stop screening if:
- Continue screening beyond 65 if inadequate prior screening or high‑risk history (e.g., CIN2+, immunosuppression).
Post‑hysterectomy
- If total hysterectomy with removal of cervix and no history of CIN2+ or cervical cancer: do NOT screen.[3]
- If history of CIN2+ or cancer, or cervix in situ (subtotal hysterectomy): continue screening as per high‑risk protocols.
3. Colorectal Cancer Screening
Population: Average‑risk adults (no personal history of colorectal cancer or certain polyps, no inflammatory bowel disease, no known hereditary syndrome such as Lynch or FAP).
Ages 45–75 years
- USPSTF: Screen all adults 45–75 years.[6]
- Start age: 45 years for average risk.
- End age: Routine up to 75 years if life expectancy adequate.
Ages 76–85 years
- Selective screening only: individualize based on overall health, life expectancy, prior screening history, and patient preferences.[6]
Main screening options and intervals (average‑risk):[6]
- Stool‑based tests
- High‑sensitivity gFOBT or FIT: every year
- Stool DNA‑FIT: every 1–3 years
- Direct visualization
- Colonoscopy: every 10 years
- CT colonography: every 5 years
- Flexible sigmoidoscopy: every 5 years, or every 10 years + annual FIT
Choice of test should consider local availability, patient preferences, prep burden, and follow‑up capacity; abnormal non‑colonoscopy tests must be followed by diagnostic colonoscopy.
4. Practical summary (average‑risk, asymptomatic)
-
Breast
- 40–74 years: mammography every 2 years.
- ≥75: individualized.
-
Cervix
- 21–29: Pap every 3 years.
- 30–65: Pap q3y OR hrHPV alone q5y OR co‑test q5y.
- <21: no screening.
-
65: stop if adequately screened and no CIN2+.
- Post‑total hysterectomy without CIN2+: no screening.
-
Colorectal
- 45–75: screen (stool tests, sigmoidoscopy, CT colonography, or colonoscopy; intervals above).
- 76–85: consider selectively.
If you tell me the country/health system and whether you want strictly Brazilian/European society recommendations, I can adapt these age cut‑offs and methods to your local guideline versions and include any specific programmatic rules.
Fontes
- https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/cervical-cancer-screening
- https://pubmed.ncbi.nlm.nih.gov/38578755
- https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening
- https://www.cdc.gov/wtc/newsBreastCancerScreening_20240517.html
- https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2021/04/updated-cervical-cancer-screening-guidelines
- https://www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/cervical-cancer-screening-adults-adolescents
- https://www.breastcancer.org/news/new-screening-guidelines-USPSTF
- https://pubmed.ncbi.nlm.nih.gov/30140884/
- https://odphp.health.gov/healthypeople/tools-action/browse-evidence-based-resources/cervical-cancer-screening
Resposta gerada por inteligência artificial a partir das fontes citadas. Verifique as fontes antes de aplicá-la.